Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8+ T Cell Responses
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.02968
Full Text
Open PDFAbstract
Available in full text
Date
December 21, 2018
Authors
Publisher
Frontiers Media SA